TY - JOUR
T1 - Intensive glycemic control and thiazolidinedione use
T2 - Effects on cortical and trabecular bone at the radius and tibia
AU - Schwartz, Ann V.
AU - Vittinghoff, Eric
AU - Margolis, Karen L.
AU - Scibora, Lesley M.
AU - Palermo, Lisa
AU - Ambrosius, Walter T.
AU - Hue, Trisha F.
AU - Ensrud, Kristine E.
PY - 2013/2/11
Y1 - 2013/2/11
N2 - Factors that contribute to bone fragility in type 2 diabetes are not well understood. We assessed the effects of intensive glycemic control, thiazolidinediones (TZDs), and A1C levels on bone geometry and strength at the radius and tibia. In a substudy of the Action to Control Cardiovascular Risk in Diabetes trial, peripheral quantitative computed tomographic (pQCT) scans of the radius and tibia were obtained 2 years after randomization on 73 participants (intensive n = 35, standard n = 38). TZD use and A1C levels were measured every 4 months during the trial. Effects of intervention assignment, TZD use, and A1C on pQCT parameters were assessed in linear regression models. Intensive, compared with standard, glycemic control was associated with 1.3 % lower cortical volumetric BMD at the tibia in men (p = 0.02) but not with other pQCT parameters. In women, but not men, each additional year of TZD use was associated with an 11 % lower polar strength strain index (SSIp) at the radius (p = 0.04) and tibia (p = 0.002) in models adjusted for A1C levels. In women, each additional 1 % increase in A1C was associated with an 18 % lower SSIp at the ultradistal radius (p = 0.04) in models adjusted for TZD use. There was no consistent evidence of an effect of intensive, compared with standard, glycemic control on bone strength at the radius or tibia. In women, TZD use may reduce bone strength at these sites. Higher A1C may also be associated with lower bone strength at the radius, but not tibia, in women.
AB - Factors that contribute to bone fragility in type 2 diabetes are not well understood. We assessed the effects of intensive glycemic control, thiazolidinediones (TZDs), and A1C levels on bone geometry and strength at the radius and tibia. In a substudy of the Action to Control Cardiovascular Risk in Diabetes trial, peripheral quantitative computed tomographic (pQCT) scans of the radius and tibia were obtained 2 years after randomization on 73 participants (intensive n = 35, standard n = 38). TZD use and A1C levels were measured every 4 months during the trial. Effects of intervention assignment, TZD use, and A1C on pQCT parameters were assessed in linear regression models. Intensive, compared with standard, glycemic control was associated with 1.3 % lower cortical volumetric BMD at the tibia in men (p = 0.02) but not with other pQCT parameters. In women, but not men, each additional year of TZD use was associated with an 11 % lower polar strength strain index (SSIp) at the radius (p = 0.04) and tibia (p = 0.002) in models adjusted for A1C levels. In women, each additional 1 % increase in A1C was associated with an 18 % lower SSIp at the ultradistal radius (p = 0.04) in models adjusted for TZD use. There was no consistent evidence of an effect of intensive, compared with standard, glycemic control on bone strength at the radius or tibia. In women, TZD use may reduce bone strength at these sites. Higher A1C may also be associated with lower bone strength at the radius, but not tibia, in women.
KW - Diabetes mellitus
KW - Hemoglobin A
KW - Peripheral quantitative computed tomography
KW - Thiazolidinedione
UR - http://www.scopus.com/inward/record.url?scp=84891500135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891500135&partnerID=8YFLogxK
U2 - 10.1007/s00223-013-9703-0
DO - 10.1007/s00223-013-9703-0
M3 - Article
C2 - 23377193
AN - SCOPUS:84891500135
VL - 92
SP - 477
EP - 486
JO - Calcified Tissue International
JF - Calcified Tissue International
SN - 0171-967X
IS - 5
ER -